E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
about
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesLenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancerSafety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysisE7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts.New therapies for dedifferentiated papillary thyroid cancerMultiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesPhase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.Effects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combinationAn update in the use of antibodies to treat glioblastoma multiforme.Metastatic melanoma - a review of current and future drugsRole of tyrosine kinase inhibitors in the management of high-grade gliomas.Progress and contrasts of the development of tivozanib for therapy of kidney cancer.Metastatic melanoma: the new era of targeted therapy.Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Novel therapies for thyroid cancer.Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.Lenvatinib: first global approval.Drug safety evaluation of lenvatinib for thyroid cancer.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.Efficacy of lenvatinib in treating thyroid cancer.MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.Personalization of targeted therapy in advanced thyroid cancer.Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas.A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer
P2860
Q26751274-44723FDA-B16D-4688-8400-6AF4394890DEQ28072655-2D9F7BA8-3501-4D33-8160-19FF3552B747Q33433315-4D7A2AB0-8AB9-483E-9483-373D399EECD4Q34558883-178A348C-3BA2-4C61-900F-7B8500ACB6D2Q35381593-750CB2E2-DEFF-421B-8E22-1E382448175FQ36438319-2095F4BB-BBC7-44B3-8879-E9C2E2D060C3Q36825455-D80604D9-30B5-43A4-B0D0-FF2BD1001854Q37309453-AF573D88-A9A8-4506-8BCA-A30D699E8E8CQ37329927-26666DBD-66FD-4EE7-B4C0-B03EDDC0799AQ37450733-FAE6AEE8-8E4A-476B-8D0A-A60362CBFDE4Q37952242-A6E88C45-EDB1-463A-9448-DD40694BC3F9Q37958038-667B4832-BD8B-406F-BADB-83DD04DAA976Q37996425-D94AC14B-8B0A-48DA-AB45-2AEE38EE9E78Q38185688-79876982-8638-4E89-89E1-041EF1494E96Q38221107-0F96DFD8-7124-4070-8F84-9C067173112DQ38260495-15CE2E0F-3256-42DF-86CF-4A660888F63AQ38323440-CEBD3F18-D531-42D0-9C24-E49CD5D98780Q38385844-9B38CA5B-A013-4D36-988E-DCDE86C76437Q38612008-76EB50BA-E39F-4B2F-AF8A-7C515975C345Q38657760-3B9ADE06-DA7F-42FF-A213-34267653A791Q38754614-9010A8B8-C178-4B87-B578-0233653ABE50Q38843403-7F33BBD3-2CCA-432E-B4CF-7E44EF7CADD8Q39015324-20B77451-BECF-4220-8861-416C408D732FQ40922523-D8BFA421-2006-4395-9318-BCE8DECC57FCQ49221322-D4631619-BE9E-470A-B337-1C74E4A98195Q54311105-7E9D1163-F8D8-4E29-8A71-0148986776D0Q58584938-19EE8CFC-3D95-4143-B51C-EE48878ED04C
P2860
E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@ast
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@en
type
label
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@ast
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@en
prefLabel
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@ast
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@en
P2093
P2860
P356
P1433
P1476
E7080, a multi-targeted tyrosi ...... or cell migration and invasion
@en
P2093
Hilary Glen
Hitesh Patel
Kenneth Macleod
Susan Mason
Valerie G Brunton
P2860
P2888
P356
10.1186/1471-2407-11-309
P407
P577
2011-07-22T00:00:00Z
P5875
P6179
1032536620